You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adjuvant melanoma

Showing 1 - 25 of 7,005
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

A Study of Adjuvant Melanoma Stakeholder Treatment Preferences

Completed
  • Melanoma
    • Melbourne, Victoria, Australia
      Local Institution
    Jun 29, 2022

    Uveal Melanoma Trial in Grand Rapids (Darovasertib)

    Recruiting
    • Uveal Melanoma
    • Grand Rapids, Michigan
      The Cancer and Hematology Centers
    Jun 14, 2023

    Improve Early Detection of Cancer Recurrence in High-Risk

    Recruiting
    • Stage III Melanoma
    • Stage IV Cutaneous Melanoma
      • Cleveland, Ohio
        Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
      Oct 6, 2022

      Melanoma, Urothelial Carcinoma Trial in Berlin (Nivolumab/rHuPH20, Nivolumab)

      Not yet recruiting
      • Melanoma
      • Urothelial Carcinoma
      • Berlin, Germany
        Local Institution - 0001
      Aug 9, 2022

      Melanoma Stage III, In-Transit Metastasis of Cutaneous Melanoma Trial in Leiden (Encorafenib + Binimetinib)

      Recruiting
      • Melanoma Stage III
      • In-Transit Metastasis of Cutaneous Melanoma
      • Encorafenib + Binimetinib
      • Leiden, Zuid-Holland, Netherlands
        Leiden University Medical Center
      Mar 2, 2023

      Healthcare Resource Utilization and Costs of Immune Checkpoint

      Completed
      • Melanoma
        • East Hanover, New Jersey
          Novartis
        May 12, 2023

        Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Shanghai (Endostar,

        Recruiting
        • Clinical Stage III Cutaneous Melanoma AJCC v8
        • Clinical Stage IV Cutaneous Melanoma AJCC v8
        • Shanghai, China
          Fudan University Shanghai Cancer Center
        Jun 17, 2023

        Immunotherapy Among BRAF-Positive Melanoma Patients Treated in

        Completed
        • Metastatic Melanoma
        • East Hanover, New Jersey
          Novartis Investigative Site
        Nov 11, 2022

        Melanoma Trial (GME751, Keytruda - EU, Keytruda - US)

        Not yet recruiting
        • Melanoma
        • (no location specified)
        Nov 22, 2023

        Melanoma Trial (V940, Pembrolizumab, Placebo)

        Not yet recruiting
        • Melanoma
        • V940
        • +2 more
        • (no location specified)
        Jul 12, 2023

        Melanoma Trial (ABP 206, FDA-licensed Nivolumab, EU-authorized Nivolumab)

        Not yet recruiting
        • Melanoma
        • ABP 206
        • +2 more
        • (no location specified)
        Jun 8, 2023

        Adverse Events-related Healthcare Resource Utilization and Costs

        Completed
        • Melanoma
        • East Hanover, New Jersey
          Novartis Pharmaceuticals
        Jan 27, 2023

        Melanoma Trial in Nedlands, Haifa, Jerusalem (Pembrolizumab/Vibostolimab, Pembrolizumab)

        Recruiting
        • Melanoma
        • Pembrolizumab/Vibostolimab
        • Pembrolizumab
        • Nedlands, Western Australia, Australia
        • +2 more
        Jan 31, 2023

        Uveal Melanoma, Uveal Melanoma, Posterior, Medium/Large Size, Eye Cancer, Intraocular Melanoma Trial in Stockholm (Melatonin)

        Not yet recruiting
        • Uveal Melanoma
        • +2 more
        • Stockholm, Sweden
          St. Erik Eye Hospital
        Aug 14, 2022

        Melanoma Trial in Fort Wayne, Barcelona (Nivolumab/rHuPH20, Nivolumab)

        Recruiting
        • Melanoma
        • Nivolumab/rHuPH20
        • Nivolumab
        • Fort Wayne, Indiana
        • +1 more
        May 10, 2022

        Melanoma Trial (Blood samples, Skin biopsy)

        Not yet recruiting
        • Melanoma
        • Blood samples
        • Skin biopsy
        • (no location specified)
        Oct 3, 2022

        Stage IIIA Melanoma Receiving Adjuvant Systemic Therapy

        Active, not recruiting
        • Melanoma
          • The Woodlands, Texas
            Local Institution
          Jun 21, 2022

          Ocular Melanoma Trial in Sydney, Melbourne (Darovasertib)

          Recruiting
          • Ocular Melanoma
          • Sydney, New South Wales, Australia
          • +1 more
          May 3, 2022

          Ovarian Reserve and Semen Parameters Evolution During Adjuvant

          Not yet recruiting
          • Melanoma
          • biological sampling
          • Marseille, France
          • +4 more
          Jun 17, 2022

          Melanoma Stage III, Melanoma Stage IV, BRAF V600 Mutation Trial in Tampa (Encorafenib Pill, Binimetinib Pill, Nivolumab)

          Recruiting
          • Melanoma Stage III
          • +2 more
          • Encorafenib Pill
          • +2 more
          • Tampa, Florida
            Moffitt Cancer Center
          May 27, 2022

          Melanoma Trial in Providence (Ipilumumab, Nivolumab)

          Active, not recruiting
          Has Results
          • Melanoma
          • Providence, Rhode Island
            Rhode Island Hospital and The Miriam Hospital
          Feb 24, 2022

          Mucosal Melanoma Trial in Wollstonecraft (Pembrolizumab, Lenvatinib)

          Not yet recruiting
          • Mucosal Melanoma
          • Wollstonecraft, New South Wales, Australia
            Melanoma Institute Australia
          Sep 15, 2022

          Melanoma, Adjuvant Trial (Dabrafenib and Trametinib, Dabrafenib, Trametinib)

          Available
          • Melanoma
          • Adjuvant
          • Dabrafenib and Trametinib
          • +2 more
          • (no location specified)
          Mar 1, 2022

          Melanoma, Ocular Melanoma Trial in United States (Nivolumab, Ipilimumab)

          Active, not recruiting
          • Melanoma
          • Ocular Melanoma
          • San Francisco, California
          • +5 more
          Aug 31, 2022

          Nivolumab Monotherapy or in Combination With Ipilimumab in

          Active, not recruiting
          • Melanoma
            • Essen, Germany
              Local Institution
            Apr 25, 2022